Skip to content

The effect of marshmallow and eucalyptus nebulizer on cough intensity in patients

Comparison of the effect of marshmallow and eucalyptus nebulizer on cough intensity among patients with COVID-19 disease

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190622043968N2
Enrollment
45
Registered
2021-12-29
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough intensity in patients with COVID-19 disease. Cough

Interventions

Intervention 1: Intervention group 1: Marshmallow, Marshmallow nebulizer 40 mg equivalent to 1 cc with 5 cc of normal saline for 15 minutes with a special nebulizer mask once a day. Intervention 2: In

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Hospitalized in COVID-19 ward of Allameh Behlool Gonabadi Hospital Definite COVID-19 disease (PCR test positive) Cough and approval by the treating physician Having almost similar cardex by all patients Being in the respiratory phase of the disease

Exclusion criteria

Exclusion criteria: Having a history of allergy to any herbal medicine Having a history of underlying respiratory disease Having an underlying disease that causes a reaction to herbal medicines

Design outcomes

Primary

MeasureTime frame
Severity of cough in patients with COVID-19 disease. Timepoint: Before the intervention, then once a day for two hours after the intervention until the end of the hospitalization period. Method of measurement: Counting the number of coughs based on Visual Analogue Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Moradi

Gonabad University of Medical Sciences

moradi.mf69@gmail.com+98 51 5722 9025

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026